Fangzhou Inc
HKEX:6086

Watchlist Manager
Fangzhou Inc Logo
Fangzhou Inc
HKEX:6086
Watchlist
Price: 2.86 HKD -0.35% Market Closed
Market Cap: 3.8B HKD

Fangzhou Inc
Investor Relations

Fangzhou, Inc. is a holding company which engages in the development of online chronic disease management platforms. The company is headquartered in Guangzhou, Guangdong and currently employs 515 full-time employees. The company went IPO on 2024-07-09. The firm operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.

Show more
Loading
6086
Hang Seng (Hong Kong)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Fangmin Xie
Chairman of the Board & CEO
No Bio Available
Mr. Yuming Zou
Executive Director, CFO & Joint Company Secretary
No Bio Available
Mr. Feng Zhou
Chief Strategy Officer & Executive Director
No Bio Available
Ms. Sau Mei Ng ACIS, ACS, FCIS, FCS
Joint Company Secretary
No Bio Available

Contacts

Address
GUANGDONG
Guangzhou
Floor 1-2, 4th Street, Building S, Kehui Jingu, No. 99, Science Avenue, Luogang Science City, Huangpu District
Contacts